文献速递胸部肿瘤

非裔美国人非小细胞肺癌全外显子组分析

Whole-Exome Profiling of NSCLC Among African Americans.
PubMed 文献 · J Thorac Oncol · 2020-09-12

该研究对82对非裔美国人肿瘤与正常组织进行全外显子测序,发现178个显著突变基因,其中5个通过FDR阈值。肺腺癌中STK11和RB1突变率显著高于欧洲裔样本,鳞癌中STK11突变率也显著更高。STK11突变肺腺癌干扰素信号降低。

要点

  • 非裔美国人肺腺癌STK11突变率25%,显著高于欧洲裔的14%(p=0.05)。
  • 非裔美国人肺腺癌RB1突变率13%,显著高于欧洲裔的4%(p=0.008)。
  • 非裔美国人鳞癌STK11突变率8%,显著高于欧洲裔的1%(p=0.002)。

核心结论

  • 非裔与欧洲裔非小细胞肺癌的体细胞突变谱大部分共享,但关键癌基因和抑癌基因的突变频率存在差异。

研究设计与样本

  • 研究对来自美国国家癌症研究所和马里兰大学正在进行的病例对照研究的82对非裔美国人肿瘤与非受累组织进行全外显子测序。

主要发现

  • 全部样本中鉴定出178个显著突变基因(p < 0.05),其中5个通过错误发现率阈值(p < 0.1)。
  • 非裔美国人肺腺癌STK11突变率为25%,欧洲裔样本为14%(p = 0.05);RB1突变率非裔为13%,欧洲裔为4%(p = 0.008)。
  • 非裔美国人鳞状细胞癌STK11突变率为8%,欧洲裔样本为1%(p = 0.002)。
  • 整合体细胞突变数据与CIBERSORT分析显示,携带STK11突变的非裔美国人肺腺癌干扰素信号降低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Lung cancer incidence is higher among African Americans (AAs) compared with European Americans (EAs) in the United States, especially among men. Although significant progress has been made profiling the genomic makeup of lung cancer in EAs, AAs continue to be underrepresented. Our objective was to chart the genome-wide landscape of somatic mutations in lung cancer tumors from AAs. METHODS: In this study, we used the whole-exome sequencing of 82 tumor and noninvolved tissue pairs from AAs. Patients were selected from an ongoing case-control study conducted by the National Cancer Institute and the University of Maryland. RESULTS: Among all samples, we identified 178 significantly mutated genes (p < 0.05), five of which passed the threshold for false discovery rate (p < 0.1). In lung adenocarcinoma (LUAD) tumors, mutation rates in STK11 (p = 0.05) and RB1 (p = 0.008) were significantly higher in AA LUAD tumors (25% and 13%, respectively) compared with The Cancer Genome Atlas EA samples (14% and 4%, respectively). In squamous cell carcinomas, mutation rates in STK11 (p = 0.002) were significantly higher among AA (8%) than EA tumors from The Cancer Genome Atlas (1%). Integrated somatic mutation data with CIBERSORT (Cell-type Identification By Estimating Relative Subsets Of RNA Transcripts) data analysis revealed LUAD tumors from AAs carrying STK11 mutations have decreased interferon signaling. CONCLUSIONS: Although a considerable degree of the somatic mutation landscape is shared between EAs and AAs, discrete differences in mutation frequency in potentially important oncogenes and tumor suppressors exist. A better understanding of the molecular basis of lung cancer in AA patients and leveraging this information to guide clinical interventions may help reduce disparities.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Arauz RF, Byun JS, Tandon M, et al. Whole-Exome Profiling of NSCLC Among African Americans. J Thorac Oncol. 2020. PMID: 32931935. doi:10.1016/j.jtho.2020.08.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。